Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Combined hormonal contraceptives and venous thromboembolism: putting the risks into perspective.

Raymond EG, Burke AE, Espey E.

Obstet Gynecol. 2012 May;119(5):1039-44. doi: 10.1097/AOG.0b013e31825194ca.

PMID:
22525916
3.
4.

SOGC clinical practice guideline. No. 252, December 2010. Oral contraceptives and the risk of venous thromboembolism: an update.

Reid R; Society of Obstetricians and Gynaecologists of Canada..

J Obstet Gynaecol Can. 2010 Dec;32(12):1192-204. English, French.

PMID:
21176332
5.

Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users.

Sidney S, Cheetham TC, Connell FA, Ouellet-Hellstrom R, Graham DJ, Davis D, Sorel M, Quesenberry CP Jr, Cooper WO.

Contraception. 2013 Jan;87(1):93-100. doi: 10.1016/j.contraception.2012.09.015. Epub 2012 Oct 19.

PMID:
23083525
6.

Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.

Sehovic N, Smith KP.

Ann Pharmacother. 2010 May;44(5):898-903. doi: 10.1345/aph.1M649. Epub 2010 Apr 6. Review.

PMID:
20371756
8.

[Venous thromboembolism in adolescents associated with fourth-generation oral contraceptives].

Botzenhardt S, Toni I, Rascher W, Neubert A.

Klin Padiatr. 2013 Sep;225(5):268-76. doi: 10.1055/s-0033-1351288. Epub 2013 Aug 26. Review. German.

PMID:
23979828
9.

Thrombotic risks of oral contraceptives.

Rott H.

Curr Opin Obstet Gynecol. 2012 Aug;24(4):235-40. doi: 10.1097/GCO.0b013e328355871d. Review.

PMID:
22729096
10.

Oral contraceptives and the risk of gallbladder disease: a comparative safety study.

Etminan M, Delaney JA, Bressler B, Brophy JM.

CMAJ. 2011 May 17;183(8):899-904. doi: 10.1503/cmaj.110161. Epub 2011 Apr 18.

11.

[Combined hormonal contraception in cycles artificially extended].

Bustillos-Alamilla E, Zepeda-Zaragoza J, Hernández-Ruiz MA, Briones-Landa CH.

Ginecol Obstet Mex. 2010 Jan;78(1):37-45. Spanish.

PMID:
20931801
13.

Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives.

Seeger JD, Loughlin J, Eng PM, Clifford CR, Cutone J, Walker AM.

Obstet Gynecol. 2007 Sep;110(3):587-93.

PMID:
17766604
14.

Combined hormonal contraceptives and the risk of venous and arterial thromboembolism and cardiovascular death: misuse of automated databases.

Shapiro S.

J Fam Plann Reprod Health Care. 2013 Apr;39(2):89-96. doi: 10.1136/jfprhc-2012-100577.

PMID:
23493593
15.
16.
17.

Risk of venous thromboembolism with drospirenone-containing oral contraceptives.

Brown DA, Vartan CM.

Am J Health Syst Pharm. 2011 Jun 1;68(11):1003-10. doi: 10.2146/ajhp100432.

PMID:
21593228
18.

Epidemiology of hormonal contraceptives-related venous thromboembolism.

Hugon-Rodin J, Gompel A, Plu-Bureau G.

Eur J Endocrinol. 2014 Dec;171(6):R221-30. doi: 10.1530/EJE-14-0527. Epub 2014 Jul 10. Review.

19.

ACOG Committee Opinion Number 540: Risk of venous thromboembolism among users of drospirenone-containing oral contraceptive pills.

Committee on Gynecologic Practice..

Obstet Gynecol. 2012 Nov;120(5):1239-42. doi: http://10.1097/AOG.0b013e318277c93b.

PMID:
23090561
20.

[Sinus thrombosis in a healthy female taking oral contraceptives].

Mogensen SS, Abild-Nielsen A, Bjarnason NH.

Ugeskr Laeger. 2011 Sep 26;173(39):2422-3. Danish.

PMID:
21958487

Supplemental Content

Support Center